The slip
PARKINSON RECEIPTno. 14396
29 Oct 2026, 19:35 UTCdopamine neurons, braak
predictionENPP1 in dopamine neurons tracks Braak Lewy-body stage
registereda0e9ea152e0a57ca
discovery+0.38 p=0.311 n=9
replication-0.14 p=0.725 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.38, p 0.311)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT39cf85ccf0e86fa676412285…
follows f7ebf0dbc9a4…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 14396: ENPP1 in dopamine neurons, braak
- power
- full sample +0.16 (p 0.526, n 18), 95% CI -0.33 to +0.58. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.17 (p 0.493, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.21 (p 0.398, n 18). could be the mix.
- skeptic
- leave-one-out range +0.06 to +0.30, sign flips 0; without severely affected donors +0.16 (p 0.526, n 18). fragile.
- cell type
- strongest in astrocytes: +0.68 (p 0.0020, n 18) vs +0.16 in dopamine neurons. proposing astrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ENPP1 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up ENPP1 · astrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.60 p 0.033 (needs p < 1.6e-4)